BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28514298)

  • 1. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.
    Qian T; Zhang B; Qian C; He Y; Li Y
    Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors.
    Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H
    Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
    Zhou CX; Zhao JH
    Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis.
    Xu Z; Ma W; Gao L; Xing B
    Tumour Biol; 2014 Apr; 35(4):3211-21. PubMed ID: 24254311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
    Xin Y; Hao S; Lu J; Wang Q; Zhang L
    PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
    Zhang H; Ge J; Hong H; Bi L; Sun Z
    World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of ERCC gene polymorphism with osteosarcoma risk.
    Wang G; Li J; Xu X; Gupta RK; Gao X
    Afr Health Sci; 2020 Dec; 20(4):1840-1848. PubMed ID: 34394247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERCC polymorphisms and risk of osteosarcoma: a meta-analysis.
    Chen XJ; Tong ZC; Kang X; Wang ZC; Huang GL; Yang TM; Dong L
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6658-6666. PubMed ID: 30402838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
    Mo J; Luo M; Cui J; Zhou S
    Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of ERCC1 and ERCC2 Gene Polymorphisms with Pancreatic Cancer Risk: A Meta-Analysis.
    Xie F; Sun Q; Zhang E; Mu Y
    Crit Rev Eukaryot Gene Expr; 2020; 30(3):231-237. PubMed ID: 32749109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between common polymorphisms in
    Li C; Yu X; Guo D; Liu G; Zhang K; Teng Q; Lin H
    Onco Targets Ther; 2018; 11():3495-3504. PubMed ID: 29950854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
    Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERCC polymorphisms and prognosis of patients with osteosarcoma.
    Li J; Liu S; Wang W; Zhang K; Liu Z; Zhang C; Chen S; Wu S
    Tumour Biol; 2014 Oct; 35(10):10129-36. PubMed ID: 25023406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between ERCC2 polymorphisms and glioma risk: a meta-analysis.
    Huang LM; Shi X; Yan DF; Zheng M; Deng YJ; Zeng WC; Liu C; Lin XD
    Asian Pac J Cancer Prev; 2014; 15(11):4417-22. PubMed ID: 24969862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes.
    Lu X; Liu Y; Yu T; Xiao S; Bao X; Pan L; Zhu G; Cai Y; Liu Q; Jin C; Yang J; Wu S; An L; van der Straaten T
    PLoS One; 2013; 8(4):e60006. PubMed ID: 23593158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
    Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY
    PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis.
    Zhao H; Wang LE; Li D; Chamberlain RM; Sturgis EM; Wei Q
    Carcinogenesis; 2008 Aug; 29(8):1560-6. PubMed ID: 18635523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis.
    Jia TL; Wu HJ; Wang HB; Ma WB; Xing B
    Genet Mol Res; 2015 Oct; 14(4):12577-84. PubMed ID: 26505408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer.
    Yu WH; Wang YX; Guo JQ; Wang YL; Zheng JS; Zhu KX
    Genet Mol Res; 2015 Dec; 14(4):17529-35. PubMed ID: 26782397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.